Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Phylogenetic analysis, paralogon groups, and fingerprints
Escalation of LT4 monotherapy is generally discouraged due to an unfavourable riskbenefit profile
My concern is that such high levels may have subtle toxic effects
The FDA label for Increlex explicitly warns of hypoglycaemia, intracranial hypertension, and slipped capital femoral epiphysis as serious adverse events
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
